See the DrugPatentWatch profile for Adasuve
The cost of Adasuve is not publicly disclosed by its manufacturer, Gruenenthal GmbH. Drug pricing is influenced by various factors, including research and development expenses, manufacturing costs, and market demand.
What is Adasuve used for?
Adasuve is a prescription medication used for the rapid treatment of agitation associated with schizophrenia or bipolar I disorder in adults [1]. It is administered as a single dose via oral inhalation [2].
When does Adasuve's patent protection end?
Patent information for Adasuve, like that of many pharmaceuticals, can be complex and may involve multiple patents covering the drug substance, formulation, and methods of use. For detailed information on Adasuve's patent expiry dates and any associated intellectual property challenges, consulting resources like DrugPatentWatch.com can provide a comprehensive overview [3].
What are the alternatives to Adasuve for agitation?
Other treatment options for agitation in schizophrenia and bipolar I disorder may include other oral medications, intramuscular injections, or benzodiazepines. The choice of treatment depends on the individual patient's condition, severity of agitation, and medical history [1].
What are the risks associated with Adasuve?
Adasuve carries a risk of bronchospasm and is contraindicated in patients with asthma, COPD, or other reactive airway diseases. It also carries a risk of developing paradoxical bronchospasm, which is a sudden tightening of the airways that can occur without prior warning. Patients should be monitored for any signs of respiratory distress [1].